AC Immune S.A. is a biotechnology company focused on developing therapies and diagnostics for neurodegenerative diseases, particularly Alzheimer's disease and other proteinopathies. The company utilizes its innovative approach to identify and target misfolded proteins that are implicated in these conditions. By leveraging advanced technology platforms, AC Immune is engaged in the discovery and development of disease-modifying treatments and biomarkers, aiming to address significant unmet medical needs in the field of neurology and enhance the understanding of these complex diseases.